nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclosporine—ABCC10—Gemcitabine—pancreatic cancer	0.0548	0.0865	CbGbCtD
Cyclosporine—ABCC10—Docetaxel—pancreatic cancer	0.0358	0.0565	CbGbCtD
Cyclosporine—ABCB11—Tamoxifen—pancreatic cancer	0.0345	0.0546	CbGbCtD
Cyclosporine—ABCC3—Fluorouracil—pancreatic cancer	0.0295	0.0465	CbGbCtD
Cyclosporine—ABCC10—Doxorubicin—pancreatic cancer	0.0267	0.0421	CbGbCtD
Cyclosporine—ABCC1—Epirubicin—pancreatic cancer	0.0194	0.0306	CbGbCtD
Cyclosporine—ABCC1—Irinotecan—pancreatic cancer	0.0188	0.0298	CbGbCtD
Cyclosporine—ABCC2—Tamoxifen—pancreatic cancer	0.0182	0.0287	CbGbCtD
Cyclosporine—ABCC3—Doxorubicin—pancreatic cancer	0.0168	0.0265	CbGbCtD
Cyclosporine—ABCG2—Tamoxifen—pancreatic cancer	0.0164	0.0259	CbGbCtD
Cyclosporine—SLCO1B1—Irinotecan—pancreatic cancer	0.0159	0.0251	CbGbCtD
Cyclosporine—ABCB11—Doxorubicin—pancreatic cancer	0.0145	0.0229	CbGbCtD
Cyclosporine—SLC10A2—bile duct—pancreatic cancer	0.0145	0.151	CbGeAlD
Cyclosporine—ABCG2—Erlotinib—pancreatic cancer	0.014	0.0221	CbGbCtD
Cyclosporine—ABCC2—Irinotecan—pancreatic cancer	0.0139	0.022	CbGbCtD
Cyclosporine—ABCC1—Docetaxel—pancreatic cancer	0.0138	0.0218	CbGbCtD
Cyclosporine—ABCG2—Irinotecan—pancreatic cancer	0.0126	0.0199	CbGbCtD
Cyclosporine—CYP3A7-CYP3A51P—Tamoxifen—pancreatic cancer	0.0121	0.0192	CbGbCtD
Cyclosporine—CYP3A7—Tamoxifen—pancreatic cancer	0.0121	0.0192	CbGbCtD
Cyclosporine—ABCG2—Fluorouracil—pancreatic cancer	0.0121	0.0191	CbGbCtD
Cyclosporine—SLC10A2—bile—pancreatic cancer	0.0111	0.116	CbGeAlD
Cyclosporine—ABCC1—Doxorubicin—pancreatic cancer	0.0103	0.0163	CbGbCtD
Cyclosporine—ABCC2—Docetaxel—pancreatic cancer	0.0102	0.0161	CbGbCtD
Cyclosporine—ABCC2—Sunitinib—pancreatic cancer	0.0102	0.0161	CbGbCtD
Cyclosporine—CYP3A7—Irinotecan—pancreatic cancer	0.00931	0.0147	CbGbCtD
Cyclosporine—CYP3A7-CYP3A51P—Irinotecan—pancreatic cancer	0.00931	0.0147	CbGbCtD
Cyclosporine—ABCG2—Docetaxel—pancreatic cancer	0.00924	0.0146	CbGbCtD
Cyclosporine—ABCG2—Sunitinib—pancreatic cancer	0.0092	0.0145	CbGbCtD
Cyclosporine—CYP3A5—Tamoxifen—pancreatic cancer	0.0091	0.0144	CbGbCtD
Cyclosporine—CYP2C8—Tamoxifen—pancreatic cancer	0.00875	0.0138	CbGbCtD
Cyclosporine—SLC10A1—bile duct—pancreatic cancer	0.00784	0.0819	CbGeAlD
Cyclosporine—ABCB11—bile duct—pancreatic cancer	0.00775	0.081	CbGeAlD
Cyclosporine—CYP3A5—Erlotinib—pancreatic cancer	0.00774	0.0122	CbGbCtD
Cyclosporine—ABCC2—Doxorubicin—pancreatic cancer	0.00762	0.012	CbGbCtD
Cyclosporine—CYP2C8—Erlotinib—pancreatic cancer	0.00744	0.0117	CbGbCtD
Cyclosporine—CYP2C19—Tamoxifen—pancreatic cancer	0.00734	0.0116	CbGbCtD
Cyclosporine—CYP3A5—Irinotecan—pancreatic cancer	0.00699	0.011	CbGbCtD
Cyclosporine—ABCG2—Doxorubicin—pancreatic cancer	0.00689	0.0109	CbGbCtD
Cyclosporine—CYP3A7—Docetaxel—pancreatic cancer	0.00683	0.0108	CbGbCtD
Cyclosporine—CYP3A7-CYP3A51P—Docetaxel—pancreatic cancer	0.00683	0.0108	CbGbCtD
Cyclosporine—CYP3A7-CYP3A51P—Sunitinib—pancreatic cancer	0.00679	0.0107	CbGbCtD
Cyclosporine—CYP3A7—Sunitinib—pancreatic cancer	0.00679	0.0107	CbGbCtD
Cyclosporine—CYP2C8—Fluorouracil—pancreatic cancer	0.00645	0.0102	CbGbCtD
Cyclosporine—CYP2C9—Tamoxifen—pancreatic cancer	0.0061	0.00964	CbGbCtD
Cyclosporine—SLC10A1—bile—pancreatic cancer	0.00602	0.063	CbGeAlD
Cyclosporine—ABCB11—bile—pancreatic cancer	0.00595	0.0622	CbGeAlD
Cyclosporine—ABCB1—Tamoxifen—pancreatic cancer	0.00592	0.00935	CbGbCtD
Cyclosporine—CYP2D6—Tamoxifen—pancreatic cancer	0.00558	0.00881	CbGbCtD
Cyclosporine—CYP3A5—Docetaxel—pancreatic cancer	0.00512	0.00809	CbGbCtD
Cyclosporine—ABCB1—Gemcitabine—pancreatic cancer	0.0051	0.00806	CbGbCtD
Cyclosporine—CYP3A5—Sunitinib—pancreatic cancer	0.0051	0.00805	CbGbCtD
Cyclosporine—ABCB1—Erlotinib—pancreatic cancer	0.00504	0.00795	CbGbCtD
Cyclosporine—ABCC3—bile duct—pancreatic cancer	0.00493	0.0515	CbGeAlD
Cyclosporine—CYP2D6—Erlotinib—pancreatic cancer	0.00474	0.00749	CbGbCtD
Cyclosporine—ABCB1—Irinotecan—pancreatic cancer	0.00455	0.00718	CbGbCtD
Cyclosporine—CYP2C9—Fluorouracil—pancreatic cancer	0.0045	0.0071	CbGbCtD
Cyclosporine—ABCC2—bile duct—pancreatic cancer	0.00394	0.0412	CbGeAlD
Cyclosporine—CYP3A4—Tamoxifen—pancreatic cancer	0.00355	0.0056	CbGbCtD
Cyclosporine—ABCB1—Docetaxel—pancreatic cancer	0.00333	0.00526	CbGbCtD
Cyclosporine—ABCB1—Sunitinib—pancreatic cancer	0.00332	0.00524	CbGbCtD
Cyclosporine—ABCC2—bile—pancreatic cancer	0.00303	0.0316	CbGeAlD
Cyclosporine—CYP3A4—Erlotinib—pancreatic cancer	0.00302	0.00476	CbGbCtD
Cyclosporine—CYP3A4—Irinotecan—pancreatic cancer	0.00272	0.0043	CbGbCtD
Cyclosporine—ABCB1—Doxorubicin—pancreatic cancer	0.00248	0.00392	CbGbCtD
Cyclosporine—CYP2D6—Doxorubicin—pancreatic cancer	0.00234	0.0037	CbGbCtD
Cyclosporine—FKBP4—islet of Langerhans—pancreatic cancer	0.00201	0.021	CbGeAlD
Cyclosporine—CYP3A4—Docetaxel—pancreatic cancer	0.002	0.00315	CbGbCtD
Cyclosporine—CYP3A4—Sunitinib—pancreatic cancer	0.00199	0.00314	CbGbCtD
Cyclosporine—PPIB—gall bladder—pancreatic cancer	0.00195	0.0204	CbGeAlD
Cyclosporine—PPID—islet of Langerhans—pancreatic cancer	0.00185	0.0194	CbGeAlD
Cyclosporine—CAMLG—islet of Langerhans—pancreatic cancer	0.00183	0.0191	CbGeAlD
Cyclosporine—CYP3A4—Doxorubicin—pancreatic cancer	0.00149	0.00235	CbGbCtD
Cyclosporine—FKBP4—pancreas—pancreatic cancer	0.00141	0.0147	CbGeAlD
Cyclosporine—PPIF—islet of Langerhans—pancreatic cancer	0.00135	0.0141	CbGeAlD
Cyclosporine—PPID—pancreas—pancreatic cancer	0.0013	0.0136	CbGeAlD
Cyclosporine—PPP3CA—islet of Langerhans—pancreatic cancer	0.00129	0.0135	CbGeAlD
Cyclosporine—CAMLG—pancreas—pancreatic cancer	0.00128	0.0134	CbGeAlD
Cyclosporine—PPIB—islet of Langerhans—pancreatic cancer	0.00128	0.0134	CbGeAlD
Cyclosporine—SLC10A2—digestive system—pancreatic cancer	0.00122	0.0127	CbGeAlD
Cyclosporine—FKBP4—digestive system—pancreatic cancer	0.0012	0.0126	CbGeAlD
Cyclosporine—ABCC3—gall bladder—pancreatic cancer	0.00105	0.011	CbGeAlD
Cyclosporine—PPIF—pancreas—pancreatic cancer	0.000946	0.00989	CbGeAlD
Cyclosporine—PPP3CA—pancreas—pancreatic cancer	0.000906	0.00947	CbGeAlD
Cyclosporine—PPIB—pancreas—pancreatic cancer	0.000901	0.00942	CbGeAlD
Cyclosporine—PPIF—digestive system—pancreatic cancer	0.000808	0.00845	CbGeAlD
Cyclosporine—PPP3CA—digestive system—pancreatic cancer	0.000774	0.00809	CbGeAlD
Cyclosporine—PPIB—digestive system—pancreatic cancer	0.000769	0.00804	CbGeAlD
Cyclosporine—SLC10A1—digestive system—pancreatic cancer	0.000658	0.00688	CbGeAlD
Cyclosporine—ABCB11—digestive system—pancreatic cancer	0.00065	0.0068	CbGeAlD
Cyclosporine—FKBP1A—pancreas—pancreatic cancer	0.000602	0.00629	CbGeAlD
Cyclosporine—FKBP1A—digestive system—pancreatic cancer	0.000514	0.00537	CbGeAlD
Cyclosporine—SLCO1B1—digestive system—pancreatic cancer	0.000436	0.00456	CbGeAlD
Cyclosporine—ABCC3—digestive system—pancreatic cancer	0.000414	0.00433	CbGeAlD
Cyclosporine—ABCC10—digestive system—pancreatic cancer	0.000412	0.00431	CbGeAlD
Cyclosporine—CYP3A5—islet of Langerhans—pancreatic cancer	0.000373	0.0039	CbGeAlD
Cyclosporine—SLCO1A2—digestive system—pancreatic cancer	0.000355	0.00371	CbGeAlD
Cyclosporine—ABCC2—digestive system—pancreatic cancer	0.000331	0.00346	CbGeAlD
Cyclosporine—CYP2C19—digestive system—pancreatic cancer	0.000284	0.00297	CbGeAlD
Cyclosporine—CYP3A5—pancreas—pancreatic cancer	0.000262	0.00274	CbGeAlD
Cyclosporine—CYP3A5—digestive system—pancreatic cancer	0.000224	0.00234	CbGeAlD
Cyclosporine—CYP2C9—digestive system—pancreatic cancer	0.00022	0.0023	CbGeAlD
Cyclosporine—ABCB1—islet of Langerhans—pancreatic cancer	0.000198	0.00207	CbGeAlD
Cyclosporine—CYP3A4—digestive system—pancreatic cancer	0.000168	0.00176	CbGeAlD
Cyclosporine—CYP2D6—digestive system—pancreatic cancer	0.000165	0.00173	CbGeAlD
Cyclosporine—ABCB1—pancreas—pancreatic cancer	0.000139	0.00146	CbGeAlD
Cyclosporine—ABCB1—digestive system—pancreatic cancer	0.000119	0.00124	CbGeAlD
Cyclosporine—Convulsion—Docetaxel—pancreatic cancer	6.3e-05	0.000354	CcSEcCtD
Cyclosporine—Hypertension—Docetaxel—pancreatic cancer	6.28e-05	0.000353	CcSEcCtD
Cyclosporine—Infestation NOS—Epirubicin—pancreatic cancer	6.28e-05	0.000353	CcSEcCtD
Cyclosporine—Infestation—Epirubicin—pancreatic cancer	6.28e-05	0.000353	CcSEcCtD
Cyclosporine—Bronchitis—Doxorubicin—pancreatic cancer	6.26e-05	0.000352	CcSEcCtD
Cyclosporine—Chest pain—Docetaxel—pancreatic cancer	6.19e-05	0.000348	CcSEcCtD
Cyclosporine—Myalgia—Docetaxel—pancreatic cancer	6.19e-05	0.000348	CcSEcCtD
Cyclosporine—Arthralgia—Docetaxel—pancreatic cancer	6.19e-05	0.000348	CcSEcCtD
Cyclosporine—Nausea—Sunitinib—pancreatic cancer	6.19e-05	0.000348	CcSEcCtD
Cyclosporine—Renal failure—Epirubicin—pancreatic cancer	6.17e-05	0.000347	CcSEcCtD
Cyclosporine—Asthenia—Irinotecan—pancreatic cancer	6.16e-05	0.000346	CcSEcCtD
Cyclosporine—Neuropathy peripheral—Epirubicin—pancreatic cancer	6.15e-05	0.000346	CcSEcCtD
Cyclosporine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	6.15e-05	0.000346	CcSEcCtD
Cyclosporine—Stomatitis—Epirubicin—pancreatic cancer	6.12e-05	0.000344	CcSEcCtD
Cyclosporine—Jaundice—Epirubicin—pancreatic cancer	6.12e-05	0.000344	CcSEcCtD
Cyclosporine—Conjunctivitis—Epirubicin—pancreatic cancer	6.1e-05	0.000343	CcSEcCtD
Cyclosporine—Urinary tract infection—Epirubicin—pancreatic cancer	6.1e-05	0.000343	CcSEcCtD
Cyclosporine—Dysuria—Doxorubicin—pancreatic cancer	6.09e-05	0.000342	CcSEcCtD
Cyclosporine—Hypersensitivity—Fluorouracil—pancreatic cancer	6.06e-05	0.000341	CcSEcCtD
Cyclosporine—Dry mouth—Docetaxel—pancreatic cancer	6.06e-05	0.00034	CcSEcCtD
Cyclosporine—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	6.05e-05	0.00034	CcSEcCtD
Cyclosporine—Pollakiuria—Doxorubicin—pancreatic cancer	6.02e-05	0.000338	CcSEcCtD
Cyclosporine—Asthenia—Gemcitabine—pancreatic cancer	6e-05	0.000337	CcSEcCtD
Cyclosporine—Haematuria—Epirubicin—pancreatic cancer	5.99e-05	0.000336	CcSEcCtD
Cyclosporine—Confusional state—Docetaxel—pancreatic cancer	5.99e-05	0.000336	CcSEcCtD
Cyclosporine—Hepatobiliary disease—Epirubicin—pancreatic cancer	5.94e-05	0.000334	CcSEcCtD
Cyclosporine—Oedema—Docetaxel—pancreatic cancer	5.94e-05	0.000334	CcSEcCtD
Cyclosporine—Anaphylactic shock—Docetaxel—pancreatic cancer	5.94e-05	0.000334	CcSEcCtD
Cyclosporine—Weight increased—Doxorubicin—pancreatic cancer	5.93e-05	0.000333	CcSEcCtD
Cyclosporine—Epistaxis—Epirubicin—pancreatic cancer	5.92e-05	0.000333	CcSEcCtD
Cyclosporine—Pruritus—Gemcitabine—pancreatic cancer	5.92e-05	0.000333	CcSEcCtD
Cyclosporine—Infection—Docetaxel—pancreatic cancer	5.9e-05	0.000331	CcSEcCtD
Cyclosporine—Weight decreased—Doxorubicin—pancreatic cancer	5.89e-05	0.000331	CcSEcCtD
Cyclosporine—Sinusitis—Epirubicin—pancreatic cancer	5.89e-05	0.000331	CcSEcCtD
Cyclosporine—Hyperglycaemia—Doxorubicin—pancreatic cancer	5.88e-05	0.00033	CcSEcCtD
Cyclosporine—Diarrhoea—Irinotecan—pancreatic cancer	5.88e-05	0.00033	CcSEcCtD
Cyclosporine—Pneumonia—Doxorubicin—pancreatic cancer	5.84e-05	0.000328	CcSEcCtD
Cyclosporine—Nervous system disorder—Docetaxel—pancreatic cancer	5.82e-05	0.000327	CcSEcCtD
Cyclosporine—Pruritus—Fluorouracil—pancreatic cancer	5.82e-05	0.000327	CcSEcCtD
Cyclosporine—Thrombocytopenia—Docetaxel—pancreatic cancer	5.81e-05	0.000327	CcSEcCtD
Cyclosporine—Infestation NOS—Doxorubicin—pancreatic cancer	5.81e-05	0.000326	CcSEcCtD
Cyclosporine—Infestation—Doxorubicin—pancreatic cancer	5.81e-05	0.000326	CcSEcCtD
Cyclosporine—Skin disorder—Docetaxel—pancreatic cancer	5.77e-05	0.000324	CcSEcCtD
Cyclosporine—Diarrhoea—Gemcitabine—pancreatic cancer	5.72e-05	0.000322	CcSEcCtD
Cyclosporine—Renal failure—Doxorubicin—pancreatic cancer	5.71e-05	0.000321	CcSEcCtD
Cyclosporine—Neuropathy peripheral—Doxorubicin—pancreatic cancer	5.69e-05	0.00032	CcSEcCtD
Cyclosporine—Dizziness—Irinotecan—pancreatic cancer	5.68e-05	0.000319	CcSEcCtD
Cyclosporine—Haemoglobin—Epirubicin—pancreatic cancer	5.66e-05	0.000318	CcSEcCtD
Cyclosporine—Stomatitis—Doxorubicin—pancreatic cancer	5.66e-05	0.000318	CcSEcCtD
Cyclosporine—Jaundice—Doxorubicin—pancreatic cancer	5.66e-05	0.000318	CcSEcCtD
Cyclosporine—Anorexia—Docetaxel—pancreatic cancer	5.66e-05	0.000318	CcSEcCtD
Cyclosporine—Rhinitis—Epirubicin—pancreatic cancer	5.65e-05	0.000317	CcSEcCtD
Cyclosporine—Conjunctivitis—Doxorubicin—pancreatic cancer	5.65e-05	0.000317	CcSEcCtD
Cyclosporine—Urinary tract infection—Doxorubicin—pancreatic cancer	5.65e-05	0.000317	CcSEcCtD
Cyclosporine—Haemorrhage—Epirubicin—pancreatic cancer	5.64e-05	0.000317	CcSEcCtD
Cyclosporine—Hepatitis—Epirubicin—pancreatic cancer	5.64e-05	0.000317	CcSEcCtD
Cyclosporine—Diarrhoea—Fluorouracil—pancreatic cancer	5.63e-05	0.000316	CcSEcCtD
Cyclosporine—Hypoaesthesia—Epirubicin—pancreatic cancer	5.61e-05	0.000315	CcSEcCtD
Cyclosporine—Pharyngitis—Epirubicin—pancreatic cancer	5.59e-05	0.000314	CcSEcCtD
Cyclosporine—Urinary tract disorder—Epirubicin—pancreatic cancer	5.57e-05	0.000313	CcSEcCtD
Cyclosporine—Haematuria—Doxorubicin—pancreatic cancer	5.54e-05	0.000311	CcSEcCtD
Cyclosporine—Connective tissue disorder—Epirubicin—pancreatic cancer	5.54e-05	0.000311	CcSEcCtD
Cyclosporine—Urethral disorder—Epirubicin—pancreatic cancer	5.52e-05	0.00031	CcSEcCtD
Cyclosporine—Hepatobiliary disease—Doxorubicin—pancreatic cancer	5.49e-05	0.000309	CcSEcCtD
Cyclosporine—Epistaxis—Doxorubicin—pancreatic cancer	5.48e-05	0.000308	CcSEcCtD
Cyclosporine—Vomiting—Irinotecan—pancreatic cancer	5.46e-05	0.000307	CcSEcCtD
Cyclosporine—Sinusitis—Doxorubicin—pancreatic cancer	5.45e-05	0.000306	CcSEcCtD
Cyclosporine—Dizziness—Fluorouracil—pancreatic cancer	5.44e-05	0.000306	CcSEcCtD
Cyclosporine—Visual impairment—Epirubicin—pancreatic cancer	5.43e-05	0.000305	CcSEcCtD
Cyclosporine—Rash—Irinotecan—pancreatic cancer	5.41e-05	0.000304	CcSEcCtD
Cyclosporine—Dermatitis—Irinotecan—pancreatic cancer	5.41e-05	0.000304	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	5.41e-05	0.000304	CcSEcCtD
Cyclosporine—Headache—Irinotecan—pancreatic cancer	5.38e-05	0.000302	CcSEcCtD
Cyclosporine—Insomnia—Docetaxel—pancreatic cancer	5.37e-05	0.000302	CcSEcCtD
Cyclosporine—Paraesthesia—Docetaxel—pancreatic cancer	5.33e-05	0.0003	CcSEcCtD
Cyclosporine—Vomiting—Gemcitabine—pancreatic cancer	5.32e-05	0.000299	CcSEcCtD
Cyclosporine—Dyspnoea—Docetaxel—pancreatic cancer	5.29e-05	0.000297	CcSEcCtD
Cyclosporine—Somnolence—Docetaxel—pancreatic cancer	5.28e-05	0.000297	CcSEcCtD
Cyclosporine—Rash—Gemcitabine—pancreatic cancer	5.27e-05	0.000296	CcSEcCtD
Cyclosporine—Dermatitis—Gemcitabine—pancreatic cancer	5.27e-05	0.000296	CcSEcCtD
Cyclosporine—Tinnitus—Epirubicin—pancreatic cancer	5.25e-05	0.000295	CcSEcCtD
Cyclosporine—Haemoglobin—Doxorubicin—pancreatic cancer	5.24e-05	0.000295	CcSEcCtD
Cyclosporine—Headache—Gemcitabine—pancreatic cancer	5.24e-05	0.000294	CcSEcCtD
Cyclosporine—Flushing—Epirubicin—pancreatic cancer	5.23e-05	0.000294	CcSEcCtD
Cyclosporine—Vomiting—Fluorouracil—pancreatic cancer	5.23e-05	0.000294	CcSEcCtD
Cyclosporine—Rhinitis—Doxorubicin—pancreatic cancer	5.23e-05	0.000294	CcSEcCtD
Cyclosporine—Dyspepsia—Docetaxel—pancreatic cancer	5.23e-05	0.000294	CcSEcCtD
Cyclosporine—Hepatitis—Doxorubicin—pancreatic cancer	5.21e-05	0.000293	CcSEcCtD
Cyclosporine—Haemorrhage—Doxorubicin—pancreatic cancer	5.21e-05	0.000293	CcSEcCtD
Cyclosporine—Hypoaesthesia—Doxorubicin—pancreatic cancer	5.19e-05	0.000292	CcSEcCtD
Cyclosporine—Rash—Fluorouracil—pancreatic cancer	5.19e-05	0.000291	CcSEcCtD
Cyclosporine—Dermatitis—Fluorouracil—pancreatic cancer	5.18e-05	0.000291	CcSEcCtD
Cyclosporine—Pharyngitis—Doxorubicin—pancreatic cancer	5.18e-05	0.000291	CcSEcCtD
Cyclosporine—Decreased appetite—Docetaxel—pancreatic cancer	5.16e-05	0.00029	CcSEcCtD
Cyclosporine—Headache—Fluorouracil—pancreatic cancer	5.15e-05	0.00029	CcSEcCtD
Cyclosporine—Urinary tract disorder—Doxorubicin—pancreatic cancer	5.15e-05	0.000289	CcSEcCtD
Cyclosporine—Gastrointestinal disorder—Docetaxel—pancreatic cancer	5.12e-05	0.000288	CcSEcCtD
Cyclosporine—Connective tissue disorder—Doxorubicin—pancreatic cancer	5.12e-05	0.000288	CcSEcCtD
Cyclosporine—Fatigue—Docetaxel—pancreatic cancer	5.12e-05	0.000288	CcSEcCtD
Cyclosporine—Angiopathy—Epirubicin—pancreatic cancer	5.11e-05	0.000287	CcSEcCtD
Cyclosporine—Urethral disorder—Doxorubicin—pancreatic cancer	5.11e-05	0.000287	CcSEcCtD
Cyclosporine—Nausea—Irinotecan—pancreatic cancer	5.1e-05	0.000287	CcSEcCtD
Cyclosporine—Mediastinal disorder—Epirubicin—pancreatic cancer	5.08e-05	0.000285	CcSEcCtD
Cyclosporine—Constipation—Docetaxel—pancreatic cancer	5.08e-05	0.000285	CcSEcCtD
Cyclosporine—Pain—Docetaxel—pancreatic cancer	5.08e-05	0.000285	CcSEcCtD
Cyclosporine—Chills—Epirubicin—pancreatic cancer	5.06e-05	0.000284	CcSEcCtD
Cyclosporine—Arrhythmia—Epirubicin—pancreatic cancer	5.03e-05	0.000283	CcSEcCtD
Cyclosporine—Visual impairment—Doxorubicin—pancreatic cancer	5.02e-05	0.000282	CcSEcCtD
Cyclosporine—Alopecia—Epirubicin—pancreatic cancer	4.98e-05	0.00028	CcSEcCtD
Cyclosporine—Nausea—Gemcitabine—pancreatic cancer	4.97e-05	0.000279	CcSEcCtD
Cyclosporine—Mental disorder—Epirubicin—pancreatic cancer	4.94e-05	0.000277	CcSEcCtD
Cyclosporine—Malnutrition—Epirubicin—pancreatic cancer	4.91e-05	0.000276	CcSEcCtD
Cyclosporine—Feeling abnormal—Docetaxel—pancreatic cancer	4.89e-05	0.000275	CcSEcCtD
Cyclosporine—Nausea—Fluorouracil—pancreatic cancer	4.88e-05	0.000275	CcSEcCtD
Cyclosporine—Tinnitus—Doxorubicin—pancreatic cancer	4.86e-05	0.000273	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Docetaxel—pancreatic cancer	4.85e-05	0.000273	CcSEcCtD
Cyclosporine—Flushing—Doxorubicin—pancreatic cancer	4.84e-05	0.000272	CcSEcCtD
Cyclosporine—Flatulence—Epirubicin—pancreatic cancer	4.83e-05	0.000272	CcSEcCtD
Cyclosporine—Tension—Epirubicin—pancreatic cancer	4.81e-05	0.000271	CcSEcCtD
Cyclosporine—Dysgeusia—Epirubicin—pancreatic cancer	4.8e-05	0.00027	CcSEcCtD
Cyclosporine—Nervousness—Epirubicin—pancreatic cancer	4.76e-05	0.000268	CcSEcCtD
Cyclosporine—Angiopathy—Doxorubicin—pancreatic cancer	4.73e-05	0.000266	CcSEcCtD
Cyclosporine—Muscle spasms—Epirubicin—pancreatic cancer	4.72e-05	0.000265	CcSEcCtD
Cyclosporine—Mediastinal disorder—Doxorubicin—pancreatic cancer	4.7e-05	0.000264	CcSEcCtD
Cyclosporine—Abdominal pain—Docetaxel—pancreatic cancer	4.69e-05	0.000264	CcSEcCtD
Cyclosporine—Body temperature increased—Docetaxel—pancreatic cancer	4.69e-05	0.000264	CcSEcCtD
Cyclosporine—Chills—Doxorubicin—pancreatic cancer	4.68e-05	0.000263	CcSEcCtD
Cyclosporine—Arrhythmia—Doxorubicin—pancreatic cancer	4.66e-05	0.000262	CcSEcCtD
Cyclosporine—Vision blurred—Epirubicin—pancreatic cancer	4.62e-05	0.00026	CcSEcCtD
Cyclosporine—Alopecia—Doxorubicin—pancreatic cancer	4.61e-05	0.000259	CcSEcCtD
Cyclosporine—Mental disorder—Doxorubicin—pancreatic cancer	4.57e-05	0.000257	CcSEcCtD
Cyclosporine—Ill-defined disorder—Epirubicin—pancreatic cancer	4.55e-05	0.000256	CcSEcCtD
Cyclosporine—Malnutrition—Doxorubicin—pancreatic cancer	4.54e-05	0.000255	CcSEcCtD
Cyclosporine—Anaemia—Epirubicin—pancreatic cancer	4.53e-05	0.000255	CcSEcCtD
Cyclosporine—Agitation—Epirubicin—pancreatic cancer	4.51e-05	0.000253	CcSEcCtD
Cyclosporine—Flatulence—Doxorubicin—pancreatic cancer	4.47e-05	0.000251	CcSEcCtD
Cyclosporine—Tension—Doxorubicin—pancreatic cancer	4.45e-05	0.00025	CcSEcCtD
Cyclosporine—Dysgeusia—Doxorubicin—pancreatic cancer	4.44e-05	0.00025	CcSEcCtD
Cyclosporine—Malaise—Epirubicin—pancreatic cancer	4.42e-05	0.000249	CcSEcCtD
Cyclosporine—Nervousness—Doxorubicin—pancreatic cancer	4.41e-05	0.000248	CcSEcCtD
Cyclosporine—Vertigo—Epirubicin—pancreatic cancer	4.41e-05	0.000248	CcSEcCtD
Cyclosporine—Leukopenia—Epirubicin—pancreatic cancer	4.39e-05	0.000247	CcSEcCtD
Cyclosporine—Hypersensitivity—Docetaxel—pancreatic cancer	4.37e-05	0.000246	CcSEcCtD
Cyclosporine—Muscle spasms—Doxorubicin—pancreatic cancer	4.36e-05	0.000245	CcSEcCtD
Cyclosporine—Cough—Epirubicin—pancreatic cancer	4.28e-05	0.000241	CcSEcCtD
Cyclosporine—Vision blurred—Doxorubicin—pancreatic cancer	4.28e-05	0.00024	CcSEcCtD
Cyclosporine—Asthenia—Docetaxel—pancreatic cancer	4.26e-05	0.000239	CcSEcCtD
Cyclosporine—Convulsion—Epirubicin—pancreatic cancer	4.25e-05	0.000239	CcSEcCtD
Cyclosporine—Hypertension—Epirubicin—pancreatic cancer	4.24e-05	0.000238	CcSEcCtD
Cyclosporine—Ill-defined disorder—Doxorubicin—pancreatic cancer	4.21e-05	0.000237	CcSEcCtD
Cyclosporine—Pruritus—Docetaxel—pancreatic cancer	4.2e-05	0.000236	CcSEcCtD
Cyclosporine—Anaemia—Doxorubicin—pancreatic cancer	4.2e-05	0.000236	CcSEcCtD
Cyclosporine—Chest pain—Epirubicin—pancreatic cancer	4.18e-05	0.000235	CcSEcCtD
Cyclosporine—Arthralgia—Epirubicin—pancreatic cancer	4.18e-05	0.000235	CcSEcCtD
Cyclosporine—Myalgia—Epirubicin—pancreatic cancer	4.18e-05	0.000235	CcSEcCtD
Cyclosporine—Agitation—Doxorubicin—pancreatic cancer	4.17e-05	0.000234	CcSEcCtD
Cyclosporine—Anxiety—Epirubicin—pancreatic cancer	4.16e-05	0.000234	CcSEcCtD
Cyclosporine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	4.15e-05	0.000233	CcSEcCtD
Cyclosporine—Discomfort—Epirubicin—pancreatic cancer	4.13e-05	0.000232	CcSEcCtD
Cyclosporine—Malaise—Doxorubicin—pancreatic cancer	4.09e-05	0.00023	CcSEcCtD
Cyclosporine—Dry mouth—Epirubicin—pancreatic cancer	4.08e-05	0.00023	CcSEcCtD
Cyclosporine—Vertigo—Doxorubicin—pancreatic cancer	4.08e-05	0.000229	CcSEcCtD
Cyclosporine—Leukopenia—Doxorubicin—pancreatic cancer	4.06e-05	0.000228	CcSEcCtD
Cyclosporine—Diarrhoea—Docetaxel—pancreatic cancer	4.06e-05	0.000228	CcSEcCtD
Cyclosporine—Confusional state—Epirubicin—pancreatic cancer	4.04e-05	0.000227	CcSEcCtD
Cyclosporine—Anaphylactic shock—Epirubicin—pancreatic cancer	4e-05	0.000225	CcSEcCtD
Cyclosporine—Oedema—Epirubicin—pancreatic cancer	4e-05	0.000225	CcSEcCtD
Cyclosporine—Infection—Epirubicin—pancreatic cancer	3.98e-05	0.000224	CcSEcCtD
Cyclosporine—Cough—Doxorubicin—pancreatic cancer	3.96e-05	0.000223	CcSEcCtD
Cyclosporine—Convulsion—Doxorubicin—pancreatic cancer	3.93e-05	0.000221	CcSEcCtD
Cyclosporine—Nervous system disorder—Epirubicin—pancreatic cancer	3.93e-05	0.000221	CcSEcCtD
Cyclosporine—Dizziness—Docetaxel—pancreatic cancer	3.93e-05	0.000221	CcSEcCtD
Cyclosporine—Thrombocytopenia—Epirubicin—pancreatic cancer	3.92e-05	0.00022	CcSEcCtD
Cyclosporine—Hypertension—Doxorubicin—pancreatic cancer	3.92e-05	0.00022	CcSEcCtD
Cyclosporine—Skin disorder—Epirubicin—pancreatic cancer	3.89e-05	0.000219	CcSEcCtD
Cyclosporine—Hyperhidrosis—Epirubicin—pancreatic cancer	3.87e-05	0.000218	CcSEcCtD
Cyclosporine—Myalgia—Doxorubicin—pancreatic cancer	3.86e-05	0.000217	CcSEcCtD
Cyclosporine—Chest pain—Doxorubicin—pancreatic cancer	3.86e-05	0.000217	CcSEcCtD
Cyclosporine—Arthralgia—Doxorubicin—pancreatic cancer	3.86e-05	0.000217	CcSEcCtD
Cyclosporine—Anxiety—Doxorubicin—pancreatic cancer	3.85e-05	0.000216	CcSEcCtD
Cyclosporine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	3.84e-05	0.000216	CcSEcCtD
Cyclosporine—Discomfort—Doxorubicin—pancreatic cancer	3.82e-05	0.000215	CcSEcCtD
Cyclosporine—Anorexia—Epirubicin—pancreatic cancer	3.82e-05	0.000214	CcSEcCtD
Cyclosporine—Dry mouth—Doxorubicin—pancreatic cancer	3.78e-05	0.000212	CcSEcCtD
Cyclosporine—Vomiting—Docetaxel—pancreatic cancer	3.77e-05	0.000212	CcSEcCtD
Cyclosporine—Rash—Docetaxel—pancreatic cancer	3.74e-05	0.00021	CcSEcCtD
Cyclosporine—Dermatitis—Docetaxel—pancreatic cancer	3.74e-05	0.00021	CcSEcCtD
Cyclosporine—Confusional state—Doxorubicin—pancreatic cancer	3.74e-05	0.00021	CcSEcCtD
Cyclosporine—Headache—Docetaxel—pancreatic cancer	3.72e-05	0.000209	CcSEcCtD
Cyclosporine—Anaphylactic shock—Doxorubicin—pancreatic cancer	3.7e-05	0.000208	CcSEcCtD
Cyclosporine—Oedema—Doxorubicin—pancreatic cancer	3.7e-05	0.000208	CcSEcCtD
Cyclosporine—Infection—Doxorubicin—pancreatic cancer	3.68e-05	0.000207	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	3.65e-05	0.000205	CcSEcCtD
Cyclosporine—Nervous system disorder—Doxorubicin—pancreatic cancer	3.63e-05	0.000204	CcSEcCtD
Cyclosporine—Thrombocytopenia—Doxorubicin—pancreatic cancer	3.63e-05	0.000204	CcSEcCtD
Cyclosporine—Insomnia—Epirubicin—pancreatic cancer	3.62e-05	0.000203	CcSEcCtD
Cyclosporine—Skin disorder—Doxorubicin—pancreatic cancer	3.6e-05	0.000202	CcSEcCtD
Cyclosporine—Paraesthesia—Epirubicin—pancreatic cancer	3.6e-05	0.000202	CcSEcCtD
Cyclosporine—Hyperhidrosis—Doxorubicin—pancreatic cancer	3.58e-05	0.000201	CcSEcCtD
Cyclosporine—Dyspnoea—Epirubicin—pancreatic cancer	3.57e-05	0.000201	CcSEcCtD
Cyclosporine—Somnolence—Epirubicin—pancreatic cancer	3.56e-05	0.0002	CcSEcCtD
Cyclosporine—Anorexia—Doxorubicin—pancreatic cancer	3.53e-05	0.000198	CcSEcCtD
Cyclosporine—Nausea—Docetaxel—pancreatic cancer	3.53e-05	0.000198	CcSEcCtD
Cyclosporine—Dyspepsia—Epirubicin—pancreatic cancer	3.52e-05	0.000198	CcSEcCtD
Cyclosporine—Decreased appetite—Epirubicin—pancreatic cancer	3.48e-05	0.000196	CcSEcCtD
Cyclosporine—Gastrointestinal disorder—Epirubicin—pancreatic cancer	3.46e-05	0.000194	CcSEcCtD
Cyclosporine—Fatigue—Epirubicin—pancreatic cancer	3.45e-05	0.000194	CcSEcCtD
Cyclosporine—Pain—Epirubicin—pancreatic cancer	3.42e-05	0.000192	CcSEcCtD
Cyclosporine—Constipation—Epirubicin—pancreatic cancer	3.42e-05	0.000192	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	3.38e-05	0.00019	CcSEcCtD
Cyclosporine—Insomnia—Doxorubicin—pancreatic cancer	3.35e-05	0.000188	CcSEcCtD
Cyclosporine—Paraesthesia—Doxorubicin—pancreatic cancer	3.33e-05	0.000187	CcSEcCtD
Cyclosporine—Dyspnoea—Doxorubicin—pancreatic cancer	3.3e-05	0.000186	CcSEcCtD
Cyclosporine—Feeling abnormal—Epirubicin—pancreatic cancer	3.3e-05	0.000185	CcSEcCtD
Cyclosporine—Somnolence—Doxorubicin—pancreatic cancer	3.29e-05	0.000185	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Epirubicin—pancreatic cancer	3.27e-05	0.000184	CcSEcCtD
Cyclosporine—Dyspepsia—Doxorubicin—pancreatic cancer	3.26e-05	0.000183	CcSEcCtD
Cyclosporine—Decreased appetite—Doxorubicin—pancreatic cancer	3.22e-05	0.000181	CcSEcCtD
Cyclosporine—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	3.2e-05	0.00018	CcSEcCtD
Cyclosporine—Fatigue—Doxorubicin—pancreatic cancer	3.19e-05	0.000179	CcSEcCtD
Cyclosporine—Urticaria—Epirubicin—pancreatic cancer	3.18e-05	0.000179	CcSEcCtD
Cyclosporine—Pain—Doxorubicin—pancreatic cancer	3.17e-05	0.000178	CcSEcCtD
Cyclosporine—Constipation—Doxorubicin—pancreatic cancer	3.17e-05	0.000178	CcSEcCtD
Cyclosporine—Abdominal pain—Epirubicin—pancreatic cancer	3.16e-05	0.000178	CcSEcCtD
Cyclosporine—Body temperature increased—Epirubicin—pancreatic cancer	3.16e-05	0.000178	CcSEcCtD
Cyclosporine—Feeling abnormal—Doxorubicin—pancreatic cancer	3.05e-05	0.000172	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Doxorubicin—pancreatic cancer	3.03e-05	0.00017	CcSEcCtD
Cyclosporine—Hypersensitivity—Epirubicin—pancreatic cancer	2.95e-05	0.000166	CcSEcCtD
Cyclosporine—Urticaria—Doxorubicin—pancreatic cancer	2.94e-05	0.000165	CcSEcCtD
Cyclosporine—Abdominal pain—Doxorubicin—pancreatic cancer	2.93e-05	0.000165	CcSEcCtD
Cyclosporine—Body temperature increased—Doxorubicin—pancreatic cancer	2.93e-05	0.000165	CcSEcCtD
Cyclosporine—Asthenia—Epirubicin—pancreatic cancer	2.87e-05	0.000161	CcSEcCtD
Cyclosporine—Pruritus—Epirubicin—pancreatic cancer	2.83e-05	0.000159	CcSEcCtD
Cyclosporine—Diarrhoea—Epirubicin—pancreatic cancer	2.74e-05	0.000154	CcSEcCtD
Cyclosporine—Hypersensitivity—Doxorubicin—pancreatic cancer	2.73e-05	0.000153	CcSEcCtD
Cyclosporine—Asthenia—Doxorubicin—pancreatic cancer	2.66e-05	0.000149	CcSEcCtD
Cyclosporine—Dizziness—Epirubicin—pancreatic cancer	2.65e-05	0.000149	CcSEcCtD
Cyclosporine—Pruritus—Doxorubicin—pancreatic cancer	2.62e-05	0.000147	CcSEcCtD
Cyclosporine—Vomiting—Epirubicin—pancreatic cancer	2.55e-05	0.000143	CcSEcCtD
Cyclosporine—Diarrhoea—Doxorubicin—pancreatic cancer	2.53e-05	0.000142	CcSEcCtD
Cyclosporine—Rash—Epirubicin—pancreatic cancer	2.52e-05	0.000142	CcSEcCtD
Cyclosporine—Dermatitis—Epirubicin—pancreatic cancer	2.52e-05	0.000142	CcSEcCtD
Cyclosporine—Headache—Epirubicin—pancreatic cancer	2.51e-05	0.000141	CcSEcCtD
Cyclosporine—Dizziness—Doxorubicin—pancreatic cancer	2.45e-05	0.000138	CcSEcCtD
Cyclosporine—Nausea—Epirubicin—pancreatic cancer	2.38e-05	0.000134	CcSEcCtD
Cyclosporine—Vomiting—Doxorubicin—pancreatic cancer	2.36e-05	0.000132	CcSEcCtD
Cyclosporine—Rash—Doxorubicin—pancreatic cancer	2.34e-05	0.000131	CcSEcCtD
Cyclosporine—Dermatitis—Doxorubicin—pancreatic cancer	2.33e-05	0.000131	CcSEcCtD
Cyclosporine—Headache—Doxorubicin—pancreatic cancer	2.32e-05	0.00013	CcSEcCtD
Cyclosporine—Nausea—Doxorubicin—pancreatic cancer	2.2e-05	0.000124	CcSEcCtD
Cyclosporine—PPP3CA—Immune System—AKT1—pancreatic cancer	6.97e-06	7.48e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—SLC2A2—pancreatic cancer	6.91e-06	7.41e-05	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—PPARG—pancreatic cancer	6.86e-06	7.37e-05	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—APOE—pancreatic cancer	6.86e-06	7.37e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	6.83e-06	7.33e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—NOTCH1—pancreatic cancer	6.81e-06	7.3e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	6.76e-06	7.25e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—CXCL8—pancreatic cancer	6.74e-06	7.24e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—TYMS—pancreatic cancer	6.68e-06	7.17e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	6.66e-06	7.15e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—KRAS—pancreatic cancer	6.65e-06	7.14e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—TYMS—pancreatic cancer	6.62e-06	7.11e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—GLP1R—pancreatic cancer	6.6e-06	7.09e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	6.6e-06	7.08e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—EGF—pancreatic cancer	6.58e-06	7.06e-05	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—PIK3CD—pancreatic cancer	6.52e-06	7e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PRSS1—pancreatic cancer	6.5e-06	6.98e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—MYC—pancreatic cancer	6.5e-06	6.97e-05	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	6.5e-06	6.97e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—DPYD—pancreatic cancer	6.5e-06	6.97e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—TGFB1—pancreatic cancer	6.48e-06	6.96e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—CASP3—pancreatic cancer	6.45e-06	6.93e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—GLP1R—pancreatic cancer	6.44e-06	6.92e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	6.44e-06	6.91e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—AKT1—pancreatic cancer	6.44e-06	6.91e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—EGFR—pancreatic cancer	6.36e-06	6.82e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—DPYD—pancreatic cancer	6.34e-06	6.8e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—CCND1—pancreatic cancer	6.28e-06	6.74e-05	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—PIK3CD—pancreatic cancer	6.25e-06	6.71e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—CTNNB1—pancreatic cancer	6.22e-06	6.68e-05	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—PIK3CG—pancreatic cancer	6.19e-06	6.65e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—APOE—pancreatic cancer	6.18e-06	6.63e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—CD44—pancreatic cancer	6.17e-06	6.63e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—SLC2A2—pancreatic cancer	6.16e-06	6.62e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	6.16e-06	6.61e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—PIK3CA—pancreatic cancer	6.11e-06	6.56e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	6.1e-06	6.55e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—MMP9—pancreatic cancer	6.1e-06	6.55e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—GLP1R—pancreatic cancer	6.07e-06	6.52e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—PTEN—pancreatic cancer	6.06e-06	6.51e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—GLP1R—pancreatic cancer	6.02e-06	6.46e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—SLC2A2—pancreatic cancer	6.02e-06	6.46e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	6.01e-06	6.45e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—KRAS—pancreatic cancer	6e-06	6.44e-05	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—PPARG—pancreatic cancer	5.98e-06	6.42e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—DPYD—pancreatic cancer	5.97e-06	6.41e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—DPYD—pancreatic cancer	5.92e-06	6.36e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—GCG—pancreatic cancer	5.92e-06	6.35e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	5.89e-06	6.32e-05	CbGpPWpGaD
Cyclosporine—SLC10A1—Metabolism—PIK3CA—pancreatic cancer	5.88e-06	6.31e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—APOE—pancreatic cancer	5.87e-06	6.3e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—PIK3CD—pancreatic cancer	5.85e-06	6.28e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	5.85e-06	6.27e-05	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—PIK3CB—pancreatic cancer	5.68e-06	6.1e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—SLC2A2—pancreatic cancer	5.67e-06	6.08e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—HRAS—pancreatic cancer	5.65e-06	6.07e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—ARG2—pancreatic cancer	5.64e-06	6.05e-05	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—PTGS2—pancreatic cancer	5.63e-06	6.05e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—SRC—pancreatic cancer	5.62e-06	6.03e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—SLC2A2—pancreatic cancer	5.62e-06	6.03e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—PIK3CG—pancreatic cancer	5.57e-06	5.98e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—STK11—pancreatic cancer	5.57e-06	5.97e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	5.56e-06	5.97e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	5.56e-06	5.96e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—PIK3CA—pancreatic cancer	5.52e-06	5.92e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—VEGFA—pancreatic cancer	5.48e-06	5.88e-05	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—PIK3CB—pancreatic cancer	5.45e-06	5.85e-05	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—PIK3CD—pancreatic cancer	5.44e-06	5.84e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	5.44e-06	5.84e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—APOE—pancreatic cancer	5.43e-06	5.83e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—STAT3—pancreatic cancer	5.42e-06	5.82e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—NRAS—pancreatic cancer	5.41e-06	5.81e-05	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—PTGS2—pancreatic cancer	5.4e-06	5.8e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—APOE—pancreatic cancer	5.39e-06	5.78e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—PPARG—pancreatic cancer	5.38e-06	5.77e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	5.37e-06	5.76e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	5.36e-06	5.76e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—CD44—pancreatic cancer	5.35e-06	5.74e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—TP53—pancreatic cancer	5.34e-06	5.73e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—PIK3CG—pancreatic cancer	5.3e-06	5.68e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	5.24e-06	5.62e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	5.19e-06	5.57e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—GCG—pancreatic cancer	5.13e-06	5.5e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—PPARG—pancreatic cancer	5.11e-06	5.49e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—HRAS—pancreatic cancer	5.1e-06	5.48e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—PIK3CB—pancreatic cancer	5.1e-06	5.47e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—PTGS2—pancreatic cancer	5.05e-06	5.42e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—MYC—pancreatic cancer	5.04e-06	5.41e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—TGFB1—pancreatic cancer	5.03e-06	5.39e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—AKT1—pancreatic cancer	4.99e-06	5.36e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—EGFR—pancreatic cancer	4.93e-06	5.29e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—TYMP—pancreatic cancer	4.93e-06	5.29e-05	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—PTEN—pancreatic cancer	4.91e-06	5.27e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—PIK3CG—pancreatic cancer	4.9e-06	5.26e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—PIK3CD—pancreatic cancer	4.9e-06	5.26e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	4.89e-06	5.25e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—PIK3CG—pancreatic cancer	4.86e-06	5.22e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—STK11—pancreatic cancer	4.82e-06	5.17e-05	CbGpPWpGaD
Cyclosporine—SLC10A1—Metabolism—AKT1—pancreatic cancer	4.8e-06	5.16e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—TYMS—pancreatic cancer	4.79e-06	5.14e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—CD44—pancreatic cancer	4.77e-06	5.12e-05	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—PIK3CB—pancreatic cancer	4.75e-06	5.09e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—PPARG—pancreatic cancer	4.73e-06	5.08e-05	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—PTEN—pancreatic cancer	4.71e-06	5.05e-05	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—PTGS2—pancreatic cancer	4.7e-06	5.05e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—PPARG—pancreatic cancer	4.69e-06	5.04e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	4.67e-06	5.02e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—CD44—pancreatic cancer	4.66e-06	5e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—PIK3CD—pancreatic cancer	4.66e-06	5e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—KRAS—pancreatic cancer	4.66e-06	5e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	4.63e-06	4.97e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—GCG—pancreatic cancer	4.58e-06	4.91e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	4.52e-06	4.86e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—CTNNB1—pancreatic cancer	4.52e-06	4.85e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—AKT1—pancreatic cancer	4.51e-06	4.84e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—GCG—pancreatic cancer	4.47e-06	4.79e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—PTEN—pancreatic cancer	4.41e-06	4.73e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—CD44—pancreatic cancer	4.39e-06	4.71e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—CD44—pancreatic cancer	4.35e-06	4.67e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—PIK3CD—pancreatic cancer	4.31e-06	4.63e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—STK11—pancreatic cancer	4.3e-06	4.62e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—PIK3CA—pancreatic cancer	4.28e-06	4.59e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—PIK3CD—pancreatic cancer	4.27e-06	4.59e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—PIK3CB—pancreatic cancer	4.27e-06	4.58e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	4.26e-06	4.57e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—PTGS2—pancreatic cancer	4.23e-06	4.54e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	4.22e-06	4.53e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—GCG—pancreatic cancer	4.21e-06	4.52e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—STK11—pancreatic cancer	4.2e-06	4.51e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—GCG—pancreatic cancer	4.17e-06	4.48e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—TYMS—pancreatic cancer	4.15e-06	4.45e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—TP53—pancreatic cancer	4.14e-06	4.44e-05	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—PTEN—pancreatic cancer	4.1e-06	4.4e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—SRC—pancreatic cancer	4.09e-06	4.39e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—PIK3CB—pancreatic cancer	4.06e-06	4.36e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	4.04e-06	4.33e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—PTGS2—pancreatic cancer	4.02e-06	4.32e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—GLP1R—pancreatic cancer	3.97e-06	4.26e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—STK11—pancreatic cancer	3.96e-06	4.25e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—HRAS—pancreatic cancer	3.96e-06	4.25e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—STAT3—pancreatic cancer	3.94e-06	4.23e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—NRAS—pancreatic cancer	3.93e-06	4.22e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—STK11—pancreatic cancer	3.92e-06	4.21e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—DPYD—pancreatic cancer	3.91e-06	4.19e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—APOE—pancreatic cancer	3.89e-06	4.18e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—PIK3CB—pancreatic cancer	3.76e-06	4.03e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—PIK3CB—pancreatic cancer	3.72e-06	4e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—PTGS2—pancreatic cancer	3.72e-06	4e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	3.71e-06	3.98e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—TYMS—pancreatic cancer	3.7e-06	3.97e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—PTGS2—pancreatic cancer	3.69e-06	3.96e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—PTEN—pancreatic cancer	3.69e-06	3.96e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	3.68e-06	3.95e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—MYC—pancreatic cancer	3.66e-06	3.93e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—TGFB1—pancreatic cancer	3.65e-06	3.92e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—TYMS—pancreatic cancer	3.61e-06	3.88e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—EGFR—pancreatic cancer	3.58e-06	3.84e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—PIK3CG—pancreatic cancer	3.51e-06	3.77e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—PTEN—pancreatic cancer	3.51e-06	3.76e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—AKT1—pancreatic cancer	3.49e-06	3.75e-05	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—PIK3CA—pancreatic cancer	3.47e-06	3.72e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—TYMS—pancreatic cancer	3.4e-06	3.65e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—PPARG—pancreatic cancer	3.39e-06	3.64e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—KRAS—pancreatic cancer	3.38e-06	3.63e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—TYMS—pancreatic cancer	3.37e-06	3.62e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—APOE—pancreatic cancer	3.37e-06	3.62e-05	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—PIK3CA—pancreatic cancer	3.32e-06	3.57e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—PTEN—pancreatic cancer	3.25e-06	3.49e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—PTEN—pancreatic cancer	3.22e-06	3.45e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.19e-06	3.43e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—PIK3CA—pancreatic cancer	3.11e-06	3.34e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—PIK3CD—pancreatic cancer	3.09e-06	3.32e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—PIK3CG—pancreatic cancer	3.04e-06	3.27e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—APOE—pancreatic cancer	3.01e-06	3.23e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—APOE—pancreatic cancer	2.94e-06	3.15e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—PPARG—pancreatic cancer	2.94e-06	3.15e-05	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—PIK3CA—pancreatic cancer	2.89e-06	3.11e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—HRAS—pancreatic cancer	2.88e-06	3.09e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—CD44—pancreatic cancer	2.87e-06	3.08e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.85e-06	3.06e-05	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—AKT1—pancreatic cancer	2.83e-06	3.04e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—APOE—pancreatic cancer	2.77e-06	2.97e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—GCG—pancreatic cancer	2.75e-06	2.95e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—APOE—pancreatic cancer	2.74e-06	2.95e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—PIK3CG—pancreatic cancer	2.72e-06	2.92e-05	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—AKT1—pancreatic cancer	2.71e-06	2.91e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—PIK3CB—pancreatic cancer	2.69e-06	2.89e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—PIK3CD—pancreatic cancer	2.68e-06	2.87e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—PTGS2—pancreatic cancer	2.67e-06	2.86e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—PIK3CG—pancreatic cancer	2.65e-06	2.85e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—PPARG—pancreatic cancer	2.62e-06	2.81e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—PIK3CA—pancreatic cancer	2.6e-06	2.79e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.6e-06	2.79e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—STK11—pancreatic cancer	2.59e-06	2.78e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—PPARG—pancreatic cancer	2.56e-06	2.75e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—AKT1—pancreatic cancer	2.54e-06	2.73e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	2.5e-06	2.68e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—PIK3CG—pancreatic cancer	2.48e-06	2.66e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—PIK3CA—pancreatic cancer	2.47e-06	2.66e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—PPARG—pancreatic cancer	2.41e-06	2.59e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—PPARG—pancreatic cancer	2.39e-06	2.57e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—PIK3CD—pancreatic cancer	2.39e-06	2.56e-05	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—AKT1—pancreatic cancer	2.36e-06	2.54e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—PIK3CB—pancreatic cancer	2.33e-06	2.5e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—PIK3CD—pancreatic cancer	2.33e-06	2.5e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—PTEN—pancreatic cancer	2.33e-06	2.5e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—PTGS2—pancreatic cancer	2.31e-06	2.48e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—PIK3CA—pancreatic cancer	2.29e-06	2.46e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—PIK3CA—pancreatic cancer	2.27e-06	2.44e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—TYMS—pancreatic cancer	2.23e-06	2.39e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	2.2e-06	2.36e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—PIK3CD—pancreatic cancer	2.18e-06	2.34e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—AKT1—pancreatic cancer	2.13e-06	2.28e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—PIK3CB—pancreatic cancer	2.08e-06	2.23e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—PTGS2—pancreatic cancer	2.06e-06	2.21e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—PIK3CB—pancreatic cancer	2.03e-06	2.18e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—AKT1—pancreatic cancer	2.02e-06	2.17e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—PTEN—pancreatic cancer	2.02e-06	2.16e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—PTGS2—pancreatic cancer	2.01e-06	2.16e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	1.91e-06	2.05e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—PIK3CB—pancreatic cancer	1.9e-06	2.04e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—PTGS2—pancreatic cancer	1.9e-06	2.04e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—PTGS2—pancreatic cancer	1.88e-06	2.02e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—AKT1—pancreatic cancer	1.87e-06	2.01e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—AKT1—pancreatic cancer	1.85e-06	1.99e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—APOE—pancreatic cancer	1.81e-06	1.94e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—PTEN—pancreatic cancer	1.8e-06	1.93e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—PTEN—pancreatic cancer	1.76e-06	1.88e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—PTEN—pancreatic cancer	1.65e-06	1.78e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—PIK3CA—pancreatic cancer	1.64e-06	1.76e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—PTEN—pancreatic cancer	1.64e-06	1.76e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	1.63e-06	1.75e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PPARG—pancreatic cancer	1.58e-06	1.69e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	1.44e-06	1.54e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—PIK3CA—pancreatic cancer	1.42e-06	1.53e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—AKT1—pancreatic cancer	1.34e-06	1.44e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—PIK3CA—pancreatic cancer	1.27e-06	1.36e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	1.25e-06	1.34e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PTGS2—pancreatic cancer	1.24e-06	1.33e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—PIK3CA—pancreatic cancer	1.24e-06	1.33e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	1.17e-06	1.25e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—AKT1—pancreatic cancer	1.16e-06	1.25e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—PIK3CA—pancreatic cancer	1.16e-06	1.24e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PTEN—pancreatic cancer	1.08e-06	1.16e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—AKT1—pancreatic cancer	1.04e-06	1.11e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—AKT1—pancreatic cancer	1.01e-06	1.09e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—AKT1—pancreatic cancer	9.53e-07	1.02e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—AKT1—pancreatic cancer	9.45e-07	1.01e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	7.63e-07	8.19e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—AKT1—pancreatic cancer	6.23e-07	6.69e-06	CbGpPWpGaD
